The courage to change the rules: A proposal for an essential health R&D treaty

PLoS Medicine

Volumn 2, Issue 2, 2005, Pages 0096-0099

  Dentico, Nicoletta ^a   Ford, Nathan ^a  

^a Neglected Diseases Group   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

NEW DRUG; DRUG;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AFRICAN TRYPANOSOMIASIS; CLINICAL RESEARCH; DEVELOPING COUNTRY; DRUG INDUSTRY; HEALTH CARE ACCESS; HEALTH CARE COST; HEALTH CARE DISTRIBUTION; HEALTH PROMOTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN RIGHTS; INFORMATION CENTER; INFORMATION DISSEMINATION; LEISHMANIASIS; MEDICAL RESEARCH; PATENT; REVIEW; SEVERE ACUTE RESPIRATORY SYNDROME; ARTICLE; ECONOMICS; EDUCATION; HEALTH; HEALTH CARE DELIVERY; HEALTH CARE POLICY; INTERNATIONAL COOPERATION; MEDICAL TECHNOLOGY; NEEDS ASSESSMENT; POLITICS;

BIOMEDICAL RESEARCH; DEVELOPING COUNTRIES; HEALTH POLICY; HEALTH SERVICES ACCESSIBILITY; HUMANS; INTERNATIONAL COOPERATION; MEDICAL LABORATORY SCIENCE; NEEDS ASSESSMENT; PATENTS AS TOPIC; PHARMACEUTICAL PREPARATIONS; POLITICS; WORLD HEALTH;

EID: 15744374725     PISSN: 15491277     EISSN: 15491676     Source Type: Journal    
DOI: 10.1371/journal.pmed.0020014     Document Type: Review

References (23)

1. Trouiller P, Olliaro P, Torreele E, Orbinski J, Laing R, et al. (2002) Drug development for neglected diseases: A deficient market and a public-health policy failure. Lancet 359: 2188-2194.
2. Lee K, Koivusalo M (2005) Trade and health: Is the health community ready for action? PLoS Med 2: e8.
3. Hubbard T, Love J (2004) A new trade framework for global healthcare R&D. PLoS Biol 2: e147.
4. World Trade Organization (2001) Declaration on the TRIPS agreement and public health. Adopted on 14 November 2001. Available: http://www.wto.org/ english/thewto_e/minist_e/min01_e/mindecl_trips_e.htm. Accessed 11 November 2004.
5. Replogle J (2004) Central American trade pact may limit access to generics. Lancet 363: 1612-1613.
6. World Health Organization (2002) The world health report 2002: Reducing risks, promoting healthy life. Geneva: World Health Organization. 250 p.
7. IMS Health (2003) IMS reports constant dollar growth in 2002 audited global pharmaceutical sales to $400.6 billion. Available: www.imshealth.com/ims/portal/front/articleC/0,2777,6599_3665_41336931,00.html. Accessed December 4, 2004.
8. Hollis A (2004) An efficient reward system for pharmaceutical innovation. Available: www.who.int/entity/intellectualproperty/news/en/Submission-Hollis6- Oct.pdf. Accessed 15 November 2004.
9. Lybecker C (2003) Rx roulette: Counterfeit pharmaceuticals in developing nations. Available: http://www.lebow.drexel.edu/lybecker/Lybecker.pdf. Accessed 15 November 2004.
10. Mahan D (2002) Profiting from pain: Where prescription drug dollars go. Available: http://www.familiesusa.org/site/DocServer/PPreport.pdf?docID=249. Accessed 3 December 2004.
11. [Anonymous] (2004 13 November) The cost of ideas. Economist: 85.
12. Gilbert J, Henske P, Singh A (2003) Rebuilding big pharma's business model. In Vivo: The Business and Medicine Report 21: 73.
13. Zacher MW (1999)Global epidemiological surveillance: International cooperation to monitor infectious diseases. In: Kaul I, Grunberg I, Stern M, editors. Global public goods: International cooperation in the 21st century. New York: Oxford University Press. pp. 266-283.
14. Maurer SM, Rai A, Sali A (2004) Finding cures for tropical diseases: Is open source an answer? PLoS Med 1: e56.
15. The Cambia BIOS initiative: Biological innovation for open society. Available: http://www.bios.net/uploads/images/16/BIOS_Initiative_CC.pdf. Accessed 15 November 2004.
16. Barbour V, Cohen B, Yamey G (2004) A new vision for clinical trials in Africa. PLoS Med 1: e71.
17. Moses H, Martin JB (2001) Academic relationships with industry: A new model for biomedical research. JAMA 285: 933-935.
18. The international treaty on plant genetic resources for food and agriculture. Available: http://www.fao.org/ag/cgrfa/itpgr.htm. Accessed 15 November 2004.
19. Yach D, Hawkes C, Gould CL, Hofman KJ (2004) The global burden of chronic diseases: Overcoming impediments to prevention and control. JAMA 291: 2616-2622.
20. UNDP human development report 1999. Available: http://hdr.undp.org/ reports/global/1999/en/, page 69.
21. NIHCM Research and Educational Foundation (2002) Changing patterns of pharmaceutical innovation. Available: http://www.nihcm.org/innovations.pdf. Accessed 4 December 2004.
22. [Anonymous] (2001 April) A look back at 2000: Overabundance and deregulation. Prescrire International 10: 52-54.
23. United States Food and Drug Administration (2004) NDAs approved in calendar years 1990-2003 by therapeutic potentials and chemical types. Available: http://www.fda.gov/cder/rdmt/pstable.htm. Accessed 9 December 2004.